KA
HLF icon

Kearns & Associates’s Herbalife HLF Stock Holding History

Kearns & Associates’s Portfolio HLF Stock Details HLF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,900
Closed -$733K – 41
2025
Q4 		$733K Hold
56,900
– – 0.38% 24
2025
Q3 		$480K Hold
56,900
– – 0.25% 31
2025
Q2 		$490K Hold
56,900
– – 0.28% 28
2025
Q1 		$491K Hold
56,900
– – 0.32% 28
2024
Q4 		$381K Hold
56,900
– – 0.25% 31
2024
Q3 		$409K Hold
56,900
– – 0.27% 27
2024
Q2 		$591K Hold
56,900
– – 0.44% 23
2024
Q1 		$572K Buy
+56,900
New +$612K 0.44% 23

Other funds holding HLF

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
ROIC
Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Kearns & Associates's HLF Position: Q1 2026 in Review

Kearns & Associates sold out of Herbalife (HLF) in Q1 2026, closing a stake of 56,900 shares — an estimated $733K sold.

Kearns & Associates first reported a position in HLF in Q1 2024 and held it in 8 quarters. The position peaked at $733K in Q4 2025. 252 funds tracked by Wall St. Rank hold HLF as of Q1 2026.

  • Kearns & Associates reported no remaining Herbalife position as of Q1 2026 after selling out during the quarter.
  • Kearns & Associates sold 56,900 Herbalife shares in Q1 2026, an estimated $733K.
  • Kearns & Associates first reported a position in Herbalife in Q1 2024 and held it in 8 quarters.
  • Kearns & Associates's Herbalife position peaked at $733K in Q4 2025.
  • 252 funds tracked by Wall St. Rank held Herbalife as of Q1 2026.

Based on Kearns & Associates's 13F filing for Q1 2026, filed 20 Apr 2026.